Lazard Asset Management
CVAC

Lazard Asset Management’s CureVac CVAC Stock Holding History

Lazard Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-105
Closed – – 2302
2024
Q2 		$0 Sell
105
-2,463
-96% -$8.05K ﹤0.01% 2267
2024
Q1 		$7K Sell
2,568
-1,422
-36% -$4.99K ﹤0.01% 1884
2023
Q4 		$16K Buy
3,990
+159
+4% +$862 ﹤0.01% 2068
2023
Q3 		$25K Buy
3,831
+177
+5% +$1.56K ﹤0.01% 2066
2023
Q2 		$37K Buy
3,654
+148
+4% +$1.32K ﹤0.01% 1923
2023
Q1 		$24K Buy
+3,506
New +$30.6K ﹤0.01% 2010

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's CVAC Position: Q3 2024 in Review

Lazard Asset Management sold out of CureVac (CVAC) in Q3 2024, closing a stake of 105 shares.

Lazard Asset Management first reported a position in CVAC in Q1 2023 and held it in 6 quarters. The position peaked at $37K in Q2 2023. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Lazard Asset Management reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Lazard Asset Management sold 105 CureVac shares in Q3 2024.
  • Lazard Asset Management first reported a position in CureVac in Q1 2023 and held it in 6 quarters.
  • Lazard Asset Management's CureVac position peaked at $37K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.